Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 7, 2018, Pages

  López Briz, Eduardo ^a   Ruiz Garcia, Vicente ^a   Cabello, Juan B ^b   Bort Martí, Sylvia ^c   Carbonell Sanchis, Rafael ^d   Burls, Amanda ^e  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c LABORATORIOS HIPRA S A   (Spain)

^d Hospital de Sagunt   (Spain)

^e CITY UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; SODIUM CHLORIDE; ANTICOAGULANT AGENT;

BLEEDING; CATHETER INFECTION; CATHETER OCCLUSION; CATHETER THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; EFFECT SIZE; FOLLOW UP; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ADULT; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; CHEMICALLY INDUCED; LAVAGE; PROCEDURES; STATISTICS AND NUMERICAL DATA; THROMBOCYTOPENIA;

ADULT; ANTICOAGULANTS; CATHETER OBSTRUCTION; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; CENTRAL VENOUS CATHETERS; HEMORRHAGE; HEPARIN; HUMANS; SODIUM CHLORIDE; THERAPEUTIC IRRIGATION; THROMBOCYTOPENIA;

EID: 85050757481     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD008462.pub3     Document Type: Review

References (239)

1. Beigi AK, HadiZadeh MS, Salimi F, Ghaheri H. Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: a randomized controlled trial. Advanced Biomedical Research 2014; Vol. 3:121. [DOI: 10.4103/2277-9175.133192]8944590
2. Bowers L, Speroni KG, Jones L, Atherton M. Comparison of occlusion rates by flushing solutions for peripherally inserted central catheters with positive pressure Luer-activated devices. Journal of Infusion Nursing 2008;31(1):22-7. 3355505
3. Dal Molin A, Clerico M, Baccini M, Guerretta L, Sartorello B, Rasero L. Normal saline versus heparin solution to lock totally implanted venous access devices: results from a multicenter randomized trial. European Journal of Oncology Nursing 2015;19(6):638-43. 8944592
4. Goossens GA, Jerome M, Janssens C, Peetermans WE, Fieuws S, Moons P, et al. Heparin versus normal saline as locking solution in totally implantable venous ports: a randomized controlled trial in cancer patients. Supportive Care in Cancer 2013;21:S28. 8944594
5. Goossens GA, Jérôme M, Janssens C, Peetermans WE, Fieuws S, Moons P, et al. Comparing normal saline versus diluted heparin to lock non-valved totally implantable venous access devices in cancer patients: a randomised, non-inferiority, open trial. Annals of Oncology 2013;24(7):1892-9. 8944593
6. Heidari Gorji MA, Rezaei F, Jafari H, Yazdani Cherati J. Comparison of the effects of heparin and 0.9% sodium chloride solutions in maintenance of patency of central venous catheters. Anesthesiology and Pain Medicine 2015;5(2):e22595. 8944596
7. Kaneko Y, Iwano M, Yoshida H, Kosuge M, Ito S, Narita I, et al. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis. Blood Purification 2004;22(5):473-9. 3355509
8. Lyons MG, Phalen AG. A randomized controlled comparison of flushing protocols in home care patients with peripherally inserted central catheters. Journal of Infusion Nursing 2014;37(4):270-81. 8944598
9. Mahesh Babu BV, Kameswara Rao AS, Rajesh K, Harinath Babu V. Heparin or 0.9% sodium chloride to maintain central venous catheter patency: a randomized trial. Journal of Evolution of Medical and Dental Sciences 2014;3(1):46-50. 8944600
10. Pumarola CF, Mercader RC, Plana MC, Bueno CC, Casellas SS, Vidal MF, et al. [Comparative study of maintenance of patency of triple lumen central venous catheter] [Estudio comparativo del mantenimiento de la permeabilidad de los cateteres venosos centrales de tres luces]. Enfermeria Intensiva 2007;18(1):25-35. 3355511
11. Rabe C, Gramann T, Sons X, Berna M, Gonzalez-Carmona MA, Klehr HU, et al. Keeping central venous lines open: a prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Medicine 2002;28(8):1172-6. 3355513
12. Schallom ME, Prentice D, Sona C, Micek ST, Skrupky LP. Heparin or 0.9% sodium chloride flush to maintain central venous catheter patency: a randomized trial. Critical Care Medicine 2012;40(6):1820-6. 3355515
13. American Association of Critical-Care Nurses. Evaluation of the effects of heparinized and nonheparinized flush solutions on the patency of arterial pressure monitoring lines: the AACN Thunder Project. By the American Association of Critical-Care Nurses. American Journal of Critical Care 1993;2(1):3-15. 3355517
14. Abdelkefi A, Othman TB, Kammoun L, Chelli M, Romdhane NB, Kriaa A, et al. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial. Thrombosis and Haemostasis 2004;92(3):654-61. 3355521
15. Abdelkefi A, Torjman L, Ladeb S, Othman TB, Achour W, Lakhal A, et al. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. Journal of Clinical Oncology 2005;23(31):7864-70. 3355523
16. Abdelkefi A. Prevention of catheter-related bloodstream infection in patients with haemato-oncological disease. clinicaltrials.gov/ct2/show/NCT00207779 (first received 13 September 2005). 3355525
17. Abdelkefi A, Achour W, Othman TB, Ladeb S, Torjman L, Lakhal A, et al. Use of heparin-coated central venous lines to prevent catheter-related bloodstream infection. Journal of Supportive Oncology 2007;5(6):273-8. 3355527
18. Abdelkefi A, Chelli M, Achour W, Ben Romdhane N, Torjman L, Ladeb S, et al. Catheter related bloodstream infection in haematological patients: a prospective, randomized study comparing heparin-coated with chlorhexidine and silver sulfadiazine impregnated central venous catheters. Blood 2008;112(11):Abstract 1174. 3355529
19. Agnelli G. Prevention of venous and arterial thromboembolism in cancer patients undergoing chemotherapy, with a low molecular weight heparin (nadroparin calcium). A randomized, placebo-controlled, double-blind, multicenter phase III study. clinicaltrials.gov/ct2/show/NCT00951574 (first received 31 July 2009). 3355531
20. Akyuz C, Kupeli S, Yagci-Kupeli B, Buyukpamukcu M. Prophylactic taurolidine use in central venous catheters of pediatric cancer patients: a prospective randomized study from single center. Pediatric Blood and Cancer 2010;55(5):949. 3355533
21. Alexander H. Heparin versus normal saline as a flush solution. International Journal for the Advancement of Science and Arts 2010;1(1):63-75. 3355535
22. Ankola PA, Atakent YS. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. American Journal of Perinatology 1993;10(3):229-32. 3355541
23. Anton N, Cox PN, Massicotte MP, Chait P, Yasui Y, Dinyari PM, et al. Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 2009;123(3):e453-8. 3355543
24. Appelgren P, Ransjo U, Bindslev L, Espersen F, Larm O. Surface heparinisation of central venous catheters reduces microbial colonization in vitro and in vivo: results from a prospective, randomized trial. Critical Care Medicine 1996;24(9):1482-9. 3355547
25. Aquino VM, Sandler ES, Mustafa MM, Steele JW, Buchanan GR. A prospective double-blind randomized trial of urokinase flushes to prevent bacteremia resulting from luminal colonization of subcutaneous central venous catheters. Journal of Pediatric Hematology/Oncology 2002;24(9):710-3. 3355549
26. Araujo C, Silva JP, Antunes P, Fernandes JM, Dias C, Pereira H, et al. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients. European Journal of Surgical Oncology 2008;34(2):222-6. 3355551
27. Arnts IJ, Heijnen JA, Wilbers HT, van der Wilt GJ, Groenewoud JMM, Liem KD. Effectiveness of heparin solution versus normal saline in maintaining patency of intravenous locks in neonates: a double blind randomized controlled study. Journal of Advanced Nursing 2011;67(12):2677-85. 3355553
28. Arrants J, Willis ME, Stevens B, Gripkey L, Herman JA, Hernandez-Brooks L, et al. Reliability of an intravenous intermittent access port (saline lock) for obtaining blood samples for coagulation studies. American Journal of Critical Care 1999;8(5):344-8. 3355557
29. Ashton J, Gibson V, Summers S. Effects of heparin versus saline solution on intermittent infusion device irrigation. Heart and Lung 1990;19(6):608-12. 3355559
30. Aslam S. Phase II trial of a novel catheter lock solution for adjunctive treatment of hemodialysis catheter-associated bacteremia. clinicaltrials.gov/ct2/show/NCT01483872 (first received 26 November 2011). 3355565
31. Bailey MJ. Reduction of catheter-associated sepsis in parenteral nutrition using low-dose intravenous heparin. British Medical Journal 1979;1(6179):1671-3. 3355567
32. Balduini C. Heparin in prophylaxis of peripheral venous catheters thrombosis: randomized clinical trial [Studio clinico randomizzato sull'utilizzo di eparina per la profilassi della tromboflebite da catetere venoso periferico]. clinicaltrials.gov/ct2/show/NCT01131754 (first received 26 May 2010). 3355569
33. Barrett PJ, Lester RL. Heparin versus saline flushing solutions in a small community hospital. Hospital Pharmacy 1990;25(2):115-8. 3355573
34. Barriga FJ, Varas M, Potin M, Sapunar F, Rojo H, Martinez A, et al. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients. Medical and Pediatric Oncology 1997;28(3):196-200. 3355575
35. Bennegard K, Curelaru I, Gustavsson B, Linder LE, Zachrisson BF. Material thrombogenicity in central venous catheterization. I. A comparison between uncoated and heparin-coated, long antebrachial, polyethylene catheters. Acta Anaesthesiologica Scandinavica 1982;26(2):112-20. 3355581
36. Bertolino G, Pitassi A, Tinelli C, Staniscia A, Guglielmana B, Scudeller L, et al. Intermittent flushing with heparin versus saline for maintenance of peripheral intravenous catheters in a medical department: a pragmatic cluster-randomized controlled study. Worldviews on Evidence-Based Nursing 2012;9(4):221-6. 3355585
37. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrology, Dialysis, Transplantation 2004;19(6):1546-51. 3355587
38. Bisseling TM, Willems MC, Versleijen MW, Hendriks JC, Vissers RK, Wanten GJ. Taurolidine lock is highly effective in preventing catheter-related bloodstream infections in patients on home parenteral nutrition: a heparin-controlled prospective trial. Clinical Nutrition 2010;29(4):464-8. 3355593
39. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infection Control and Hospital Epidemiology 2005;26(6):520-4. 3355595
40. Bolgiano CS, Subramaniam PT, Montanari JM, Minick L. The effect of two concentrations of heparin on arterial catheter patency. Critical Care Nurse 1990;10(5):47-57. 3355597
41. Branger B, Reboul P, Prelipcean C, Noguera ME, Cariou S, Granolleras C, et al. Tunnelled internal jugular vein catheters with taurolidine lock: an acceptable challenge to arterio-venous fistula in 70 years old haemodialyzed patients: a prospective pilot study. Nephrologie and Therapeutique 2011;7(4):237-41. 3355605
42. Branson PK, McCoy RA, Phillips BA, Clifton GD. Efficacy of 1.4 percent sodium citrate in maintaining arterial catheter patency in patients in a medical ICU. Chest 1993;103(3):882-5. 3355607
43. Brismar B, Hardstedt C, Jacobson S, Kager L, Malmborg AS. Reduction of catheter-associated thrombosis in parenteral nutrition by intravenous heparin therapy. Archives of Surgery 1982;117(9):1196-9. 3355609
44. Broom JK, O'Shea S, Govindarajulu S, Playford EG, Hawley CM, Isbel NM, et al. Rationale and design of the HEALTHY-CATH trial: a randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients. BMC Nephrology 2009;10:23. 3355611
45. Broom JK, Krishnasamy R, Hawley CM, Playford EG, Johnson DW. A randomised controlled trial of Heparin versus EthAnol Lock THerapy for the prevention of Catheter Associated infecTion in Haemodialysis patients - The HEALTHY-CATH trial. BMC Nephrology 2012;13:146. 3355613
46. Butt W, Shann F, McDonnell G, Hudson I. Effect of heparin concentration and infusion rate on the patency of arterial catheters. Critical Care Medicine 1987;15(3):230-2. 3355617
47. Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artificial Organs 1998;22(11):945-7. 3355619
48. Campos RP, do Nascimento MM, Chula DC, Riella MC. Minocycline-EDTA lock solution prevents catheter-related bacteremia in hemodialysis. Journal of the American Society of Nephrology 2011;22(10):1939-45. 3355627
49. Cardinal P, Allan J, Pham B, Hindmarsh T, Jones G, Delisle S. The effect of sodium citrate in arterial catheters on acid-base and electrolyte measurements. Critical Care Medicine 2000;28(5):1388-92. 3355629
50. Carrasco MN, Bueno A, De Las Cuevas C, Jimenez S, Salinas I, Sartorius A, et al. Evaluation of a triple-lumen central venous heparin-coated catheter versus a catheter coated with chlorhexidine and silver sulphadiazine in critically ill patients. Intensive Care Medicine 2004;30(4):633-8. 3355631
51. Carratala J, Niubo J, Fernandez-Sevilla A, Juve E, Castellsague X, Berlanga J, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrobial Agents and Chemotherapy 1999;43(9):2200-4. 3355633
52. Casale KE, Horst MA, Anderson AS, Devereux RB. Lower concentration of heparinized flush solution is associated with a higher incidence of femoral sheath clot following diagnostic cardiac catheterization. Journal of the American College of Cardiology 2009;53(10 Suppl 1):A24. 3355637
53. Catorze N, Teixeira S, Cabrita J, Carreto J, Vieira V, Gonçalves S, et al. Maintenance of arterial catheters with heparin; should we continue?. Critical Care 2011;15(Suppl 1):P78. 3355639
54. Catton JA, Davies J, Dobbins BM, Wood JM, McMahon MJ, Burke D. The effect of heparin in peripheral intravenous nutrition via a fine-bore midline: a randomised double-blind controlled trial. Clinical Nutrition 2006;25(3):394-9. 3355641
55. Chen F-K, Li J-J, Song Y, Zhang Y-Y, Chen P, Zhao C-Z, et al. Concentrated sodium chloride catheter lock solution - a new effective alternative method for hemodialysis patients with high bleeding risk. Renal Failure 2014;36(1):17-22. 8944602
56. Cheronis JC. Multi-center, prospective, randomized, open-label, sponsor-blinded, active-control (heparin) clinical investigation to evaluate the safety and effectiveness of B-Lock™ as an antimicrobial catheter lock solution in dialysis patients with a central venous catheter. clinicaltrials.gov/ct2/show/NCT01989091 (first received 30 October 2013). 3355647
57. Chu KH, Cheung W, Chan W, Fung KS, Tang HL, Yim KF, et al. A single centre experience of using gentamicin/heparin lock solution in preventing dialysis catheter-related infection. Hemodialysis International 2009;13(3):372. 3355649
58. Clifton GD, Branson P, Kelly HJ, Dotson LR, Record KE, Phillips BA, et al. Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency. Heart and Lung 1991;20(2):115-8. 3355653
59. Coli L, Donati G, Cianciolo G, Raimondi C, Comai G, Panicali L, et al. Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheters (TCC) thrombosis. Journal of Vascular Access 2006;7(3):118-22. 3355655
60. Conte GF, Aravena PC, Fardella PD, Araos DM, Alfaro JI, Flores CA, et al. Prophylaxis of venous thrombosis (VT) associated with central venous catheter (CVC) with low molecular weight heparin (LMWH) in hematologic malignancies [abstract]. Blood 2003; Vol. 102, issue 11:122b. 3355657
61. Coplon N. Prophylactic antimicrobial catheter lock in hemodialysis patients: a randomized controlled clinical trial. clinicaltrials.gov/ct2/show/NCT00571259 (first received 10 December 2007). 3355659
62. Corbett R, Ashby D, Edwards C, Prout V, Singh S, Bedi R, Duncan N. A randomised control trial of taurolidine-heparin-citrate line locks in prevention of recurrence of catheter related bacteraemia in haemodialysis patients. Nephrology Dialysis Transplantation 2013;28(Suppl 1):i19. 3355661
63. Cortes J. Prospective, randomized trial comparing heparin and minocycline-EDTA flush for the prevention of catheter-related infections and occlusions. clinicaltrials.gov/ct2/show/NCT00378781 (first received 16 September 2006). 3355663
64. Daniell HW. Heparin in the prevention of infusion phlebitis. A double-blind controlled study. JAMA 1973;226(11):12317-21. 3355673
65. Davanipur M, Pakfetrat M, Roozbeh J. Cloxacillin as an antibiotic lock solution for prevention of catheter-associated infection. Iranian Journal of Kidney Diseases 2011;5(5):328-31. 3355675
66. De Cicco M, Matovic M, Balestreri L, Steffan A, Pacenzia R, Malafronte M, et al. Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographies. Annals of Oncology 2009;20(12):1936-42. 3355679
67. de la Torre Montero JC, Montealegre Sanz M. Heparinization versus salinization in short peripheral catheters for blood draws in clinical trials [Heparinización versus salinización en catéteres periféricos cortos para extracciones de sangre en ensayos clínicos]. Metas de Enfermeria 2012;15(7):15-8. 3355681
68. del Cotillo M, Grane N, Llavore M, Quintana S. Heparinized solution vs. saline solution in the maintenance of arterial catheters: a double blind randomized clinical trial. Intensive Care Medicine 2008;34(2):339-43. 3355683
69. del Pozo JL. Concentration and antibiotic activity in antibiotic lock solutions. clinicaltrials.gov/ct2/show/NCT01592032 (first received 24 April 2012). 3355685
70. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, et al. Prevention of tunnelled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. Journal of the American Society of Nephrology 2002;13(8):2133-9. 3355693
71. Donham JA, Denning V. Heparin vs. saline in maintaining patency, intermittent infusion devices: pilot study. Kansas Nurse 1987;62(11):6-7. 3355695
72. Duncan N, Singh S, Amao M, Brown W, Dalby E, Edwards C, et al. A single centre randomised control trial of sodium citrate versus heparin line locks for cuffed central venous catheters [abstract no: F-PO539]. Journal of the American Society of Nephrology 2005; Vol. 16:451A. 3355699
73. Duncan N. A randomised controlled trial of taurolidine with heparin for prevention of recurrence of catheter related bacteraemia in haemodialysis patients. clinicaltrials.gov/ct2/show/NCT01243710 (accessed 6 October 2014). 3355701
74. Dünser MW, Mayr AJ, Hinterberger G, Flörl CL, Ulmer H, Schmid S, et al. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters. Anesthesia and Analgesia 2005;101(6):1778-84. 3355703
75. Eloy R, Belleville J, Paul J, Pusineri C, Baguet J, Rissoan MC, et al. Thromboresistance of bulk heparinized catheters in human. Thrombosis Research 1987;45(3):223-33. 3355709
76. Epperson EL. Efficacy of 0.9% sodium chloride injection with and without heparin for maintaining indwelling intermittent injection sites. Clinical Pharmacy 1984;3(6):626-9. 3355711
77. Garay Rubio T, Urruela Oliván M, Hernando Uzkudun A, Asensio Bermejo B, Cossío Díaz C. Effectivity [sic] of saline versus heparinized solution in flushing clogged peripheral catheter [Efectividad en la utilización de suero salino frente a suero salino heparinizado para el lavado de catéteres periféricos obturados]. Enfermeria Clinica 2011;11(6):283-8. 3355727
78. Garrelts JC, LaRocca J, Ast D, Smith DF Jr, Sweet DE. Comparison of heparin and 0.9% sodium chloride injection in the maintenance of indwelling intermittent i.v. devices. Clinical Pharmacy 1989;8(1):34-9. 3355731
79. Glaspy JA. A phase III randomized, double-blind, placebo-controlled study to evaluate the effects of fragmin (5, 000 IU subcutaneously) in preventing catheter-related complications when given daily to cancer patients with central venous catheters. clinicaltrials.gov/ct2/show/NCT00006083 (first received 3 August 2000). 3355737
80. Goh LJ, Teo HS, Masagoes M. Heparinised saline versus normal saline in maintaining patency of arterial and central venous catheters. Proceedings of Singapore Healthcare 2011;20(3):190-6. 3355739
81. Goode CJ, Kleiber C, Titler M, Small S, Rakel B, Steelman VM, et al. Improving practice through research: the case of heparin vs. saline for peripheral intermittent infusion devices. MEDSURG Nursing 1993;2(1):23-7. 3355745
82. Griffin MP, Siadaty MS. Papaverine prolongs patency of peripheral arterial catheters in neonates. Journal of Pediatrics 2005;146(1):62-5. 3355747
83. Grosso P, Martello L, Petrini PL, Massei R. Prevention of vena cava thrombosis during catheterization. Comparison of calciheparin and defibrotide. Minerva Anestesiologica 1989;55(6):273-6. 3355749
84. Gyr P, Burroughs T, Smith K, Mahl C, Pontious S, Swerczek L. Double blind comparison of heparin and saline flush solutions in maintenance of peripheral infusion devices. Pediatric Nursing 1995;21(4):383-9. 366. 3355753
85. Hall KF, Bennetts TM, Whitta RK, Welman L, Rawlins P. Effect of heparin in arterial line flushing solutions on platelet count: a randomised double-blind study. Critical Care and Resuscitation 2006;8(4):294-6. 3355755
86. Hamilton RA, Plis JM, Clay C, Sylvan L. Heparin sodium versus 0.9% sodium chloride injection for maintaining patency of indwelling intermittent infusion devices. Clinical Pharmacy 1988;7(6):439-43. 3355757
87. Han X, Yang X, Huang B, Yuan L, Cao Y. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis. Clinical Nephrology 2016;86(1):1-8. 8944604
88. Harter C, Salwender HJ, Bach A, Egerer G, Goldschmidt H, Ho AD. Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: a prospective comparison of silver-coated and uncoated catheters. Cancer 2002;94(1):245-51. 3355767
89. Haynes BJ, Quarles AW, Vavrinchik J, White J, Pedan A. The LifeSite hemodialysis access system: implications for the nephrology nurse. Nephrology Nursing Journal 2002;29(1):27-33, 72. 3355769
90. Hemmelgarn BR, Moist LM, Lok CE, Tonelli M, Manns BJ, Holden RM, et al. for the Prevention of Dialysis Catheter Lumen Occlusion with rt-PA versus Heparin (PreCLOT) Study Group. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator. New England Journal of Medicine 2011;364(4):303-12. 3355775
91. Hendrickx L, Kuypers D, Evenepoel P, Maes B, Messiaen T, Vanrenterghem Y. A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters. International Journal of Artificial Organs 2001;24(4):208-11. 3355777
92. Heng A-E, Abdelkader MH, Diaconita M, Nony A, Guerraoui A, Caillot N, et al. Impact of short term use of interdialytic 60% ethanol lock solution on tunneled silicone catheter dysfunction. Clinical Nephrology 2011;75(6):534-41. 3355779
93. HGU Gregorio Marañón. Clinical study of ethanol lock-therapy in the prevention of non-tunnelled, short term central venous catheter associated infections. clinicaltrials.gov/ct2/show/NCT01229592 (first received 18 October 2012). 3355783
94. Hoffer EK, Borsa J, Santulli P, Bloch R, Fontaine AB. Prospective randomized comparison of valved versus nonvalved peripherally inserted central vein catheters. American Journal of Roentgenology 1999;173(5):1393-8. 3355787
95. Horne MK III, May DJ, Alexander HR, Steinhaus EP, Whitman ED, Chang RC, et al. Venographic surveillance of tunneled venous access devices in adult oncology patients. Annals of Surgical Oncology 1995;2(2):174-8. 3355793
96. Hryszko T, Brzosko S, Mysliwiec M. Low concentration of heparin used for permanent catheters canal locking is effective and diminishes the risk of bleeding. International Urology and Nephrology 2013;45(3):825-9. 3355797
97. Hu HH, Hsu CY, Fang HC, Lee PT, Chen CL, Chang TY, et al. Low-dose heparin retention in temporary hemodialysis double-lumen catheter does not increase catheter occlusion and might reduce risk of bleeding. Blood Purification 2011;32(3):232-7. 3355799
98. Imamovic G. Randomized control trial on citrate as the central venous catheter lock solution. clinicaltrials.gov/ct2/show/NCT00862966 (first received 13 March 2009). 3355801
99. Ishii Y, Mishima S, Yukioka T. Comparison of normal saline and heparinized solutions for maintenance of arterial catheter pressure waves. Academic Emergency Medicine 2013;20(5 Suppl 1):s248. 3355803
100. Israel Ministry of Health. Addition of heparin to taurolock-TM CLS in HD patients with TCC: does it improve catheter patency problems?. clinicaltrials.gov/ct2/show/NCT00749619 (first received 7 September 2008). 3355805
101. Jasinsky L, Wurster J. Occlusion reduction and heparin elimination trial using an anti-reflux device on central intravenous lines. Journal of the Association for Vascular Access 2007;12(4):205. 3355811
102. Jeppesen PB. A double blinded, randomized, controlled investigation of taurolidine-citrate/heparin catheter lock solution versus heparin in patients on home parenteral nutrition with previously proven high risk of catheter related blood stream infections. clinicaltrials.gov/ct2/show/NCT01948245 (first received 16 September 2013). 3355813
103. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrology Dialysis Transplantation 2002;17(10):1802-7. 3355815
104. Jonkers C, Looman KI, Tabbers MM, Tas TA, Serlie MJ. Incidence of central venous catheter related bloodstream infections in adults and children on home parenteral nutrition: heparin versus taurolidine catheter lock. Clinical Nutrition Supplements 2012;7(1):203-4. 3355819
105. Jowett NI, Stephens JM, Thompson DR, Sutton TW. Do indwelling cannulae on coronary care units need a heparin flush?. Intensive Care Nursing 1986;2(1):16-9. 3355821
106. Kankanala S, Smith K, Henner DE. Efficacy and safety of a 4% sodium citrate locking solution in cuffed tunneled hemodialysis catheters compared with heparin. American Journal of Kidney Diseases 2012;59(4):A45. 3355827
107. Karthaus M, Kretzschmar A, Kroning H, Biakhov M, Irwin D, Marschner N, et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Annals of Oncology 2006;17(2):289-96. 3355829
108. Kokenge T, Lohofener C, Lange C, Grundemann C, Bergmann K, Januschkewitz K, et al. Efficacy and safety of a low-dose citrate catheter locking solution. A randomized double blind controlled trial. NDT Plus 2010;3(3):iii162. 3355837
109. Kovacs MJ. A pilot study of central venous catheter survival in cancer patients using low molecular weight heparin (dalteparin) for the treatment of deep vein thrombosis of the upper extremity. clinicaltrials.gov/ct2/show/NCT00216866 (first received 19 September 2005). 3355841
110. Kudsk KA, Powell C, Mirtallo JM, Fabri PJ, Ruberg RL. Heparin does not reduce catheter sepsis during total parenteral nutrition. Journal of Parenteral and Enteral Nutrition 1985;9(3):348-9. 3355847
111. Kulkarni M, Elsner C, Ouellet D, Zeldin R. Heparinized saline versus normal saline in maintaining patency of the radial artery catheter. Canadian Journal of Surgery 1994;37(1):37-42. 3355849
112. Lacasaña Bellmunt P, Garcia Ortega MJ, Garcia Ruiz C, Palomino Gutierrez B, Toro Padilla R, Vila Sanchez A, et al. Permeabilisation of peripheral venous catheters of intermittent use: with and without heparin [Permeabilización de catéteres venosos periféricos de uso intermitente: con y sin heparina]. Metas de Enfermeria 2006;9(7):10-6. 3355853
113. Lavau-Denes S, Lacroix P, Maubon A, Preux PM, Genet D, Venat-Bouvet L, et al. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study. Cancer Chemotherapy and Pharmacology 2013;72(1):65-73. 3355855
114. Le Corre I, Delorme M, Cournoyer S. A prospective, randomized trial comparing a transparent dressing and a dry gauze on the exit site of long term central venous catheters of hemodialysis patients. Journal of Vascular Access 2003;4(2):56-61. 3355857
115. Leslie GD, Jacobs IG, Clarke GM. Proximally delivered dilute heparin does not improve circuit life in continuous venovenous haemodiafiltration. Intensive Care Medicine 2011;22(11):1261-4. 3355865
116. Liang Y, Wang Y, Li D. Clinical observation on normal saline of tube-sealing solution for vein permanent needle. Shanxi Nursing Journal 1998;12(2):80-1. 3355867
117. Liang H, Liu XS, Wu YC, Zhang L, Lin QZ, Jie XN, et al. Ultra-low dose heparin locks perform well on non-tunnelled temporary haemodialysis catheters. Nephrology (Carlton, Vic.) 2015; Vol. 20, issue 4:307-8. [PUBMED: 25810232]8944606
118. Liao S, Zhang Y, Chen L. Comparison of effects on sealing up the infusion tube by using three different solutions. Chinese Nursing Research 2002;16(2):87-8. 3355869
119. Lindblad B, Bergqvist D, Wakefield TW, Stanley JC. Time-related anticoagulation after regional and systemic administration of heparin in patients undergoing aortoiliac surgery. European Journal of Vascular Surgery 1994;8(5):574-7. 3355871
120. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RMA. Trisodium citrate 4% - an alternative to heparin capping of haemodialysis catheters. Nephrology Dialysis Transplantation 2007;22(2):477-83. 3355873
121. Long DA, Coulthard MG. Effect of heparin-bonded central venous catheters on the incidence of catheter-related thrombosis and infection in children and adults. Anaesthesia and Intensive Care 2006;34(4):481-4. 3355877
122. Lustig A, Aflalu S. Novel catheter lock solution in prevention of hemodialysis catheter complications. Journal of Clinical Pharmacology 2011;51(9):1342. 3355879
123. Macrae JM, Dojcinovic I, Djurdjev O, Jung B, Shalansky S, Levin A, Kiaii M. Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clinical Journal of the American Society of Nephrology 2008;3(2):369-74. 3355881
124. Maki DG, Ash SR, Winger RK, Lavin P, AZEPTIC Trial Investigators. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial. Critical Care Medicine 2011;39(4):613-20. 3355883
125. Malo J, Jolicoeur C, Theriault F, Lachaine J, Senecal L. Comparison between standard heparin and tinzaparin for haemodialysis catheter lock. ASAIO Journal (American Society for Artificial Internal Organs) 2010;56(1):42-7. 3355887
126. Marin MG, Lee JC, Skurnick JH. Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters. Critical Care Medicine 2000;28(9):3332-8. 3355889
127. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney International 2004;66(2):801-5. 3355901
128. Meier P, Meier R, Turini P, Friolet R, Blanc E. Prolonged catheter survival in patients with acute kidney injury on continuous renal replacement therapy using a less thrombogenic micropatterned polymer modification. Nephrology Dialysis Transplantation 2011;26(2):628-35. 3355905
129. Meyer BA, Little CJ, Thorp JA, Cohen GR, Yeast JD. Heparin versus normal saline as a peripheral line flush in maintenance of intermittent intravenous lines in obstetric patients. Obstetrics and Gynecology 1995;85(3):433-6. 3355909
130. Mismetti P, Mille D, Laporte S, Charlet V, Buchmuller-Cordier A, Jacquin JP, et al. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 2003;88(1):67-73. 3355913
131. Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin). Thrombosis and Haemostasis 1996;75(2):251-3. 3355919
132. Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. American Journal of Kidney Diseases 2012;59(1):102-7. 3355921
133. Mortazavi M, Alsaeidi S, Sobhani R, Salimi F, Atapour A, Sharif N, et al. Succesful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime. Journal of Research in Medical Sciences 2011;16(3):303-9. 3355923
134. Mudge B, Forcier D, Slattery MJ. Patency of 24-gauge peripheral intermittent infusion devices: a comparison of heparin and saline flush solutions. Pediatric Nursing 1998;24(2):142-5, 149. 3355925
135. Na HS. Influence by heparinized flush solution of the radial artery catheter: INTEM and HEPTEM analysis. clinicaltrials.gov/ct2/show/NCT01522846 (first received 9 January 2012). 3355929
136. NCT03114722. Citrate 4% versus heparinised saline in preventing peripherally inserted central catheter (PICC) occlusions. clinicaltrials.gov/show/NCT03114722 (date first received 14 April 2017). 8944608
137. Niers TMH, Di Nisio M, Klerk CPW, Baarslag HJ, Buller HR, Biemond BJ. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study. Journal of Thrombosis and Haemostasis 2007;5(9):1878-82. 3355931
138. Niesen KM, Harris DY, Parkin LS, Henn LT. The effects of heparin versus normal saline for maintenance of peripheral intravenous locks in pregnant women. Journal of Obstetric Gynecologic and Neonatal Nursing 2003;32(4):503-8. 3355933
139. Nieto-Rodriguez JA, Garcia-Martin MA, Barreda-Hernandez MD, Hervas MJ, Cano-Real O. Heparin and infusion phlebitis: a prospective study. Annals of Pharmacotherapy 1992;26(10):1211-4. 3355935
140. NIH Clinical Centers. Heparin vs. lepirudin flushes in preventing withdrawal occlusion of tunneled, open-ended venous access devices: a blinded, randomized, clinical trial. clinicaltrials.gov/ct2/show/NCT00039767 (first received 7 June 2002). 3355937
141. Nori US, Manoharan A, Yee J, Besarab A. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. American Journal of Kidney Diseases 2006;48(4):596-605. 3355939
142. Oguzhan N, Pala C, Sipahioglu MH, Cilan H, Durmaz S, Percin D, et al. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomised, prospective trial. Renal Failure 2012;34(2):181-8. 3355943
143. Oran NT, Eser I. Impact of heparin locking frequency on preventing temporary dialysis catheter dysfunction in haemodialysis patients. Journal of Renal Care 2008;34(4):199-202. 3355949
144. Periard D, Monney P, Waeber G, Zurkinden C, Mazzolai L, Hayoz D, et al. Randomized controlled trial of peripherally inserted central catheters vs. peripheral catheters for middle duration in-hospital intravenous therapy. Journal of Thrombosis and Haemostasis 2008;6(8):1281-8. 3355953
145. Pervez A, Ahmed M, Ram S, Torres C, Work J, Zaman F, et al. Antibiotic lock technique for prevention of cuffed tunnel catheter associated bacteremia. Journal of Vascular Access 2002;3(3):108-13. 3355955
146. Phulara U. Effectiveness of normal saline flush versus heparin saline flush in maintaining the patency of peripheral intravenous cannula and on occurrence of intravenous focal vascular complications in patients receiving intermittent intravenous medications. Nursing Journal of India 2018;109(2):51-5. 8944610
147. Pouw L, Kilsby D, Francis P, Tulloh B. Heparin thromboprophylaxis via indwelling subcutaneous teflon cannula. Australian and New Zealand Journal of Surgery 1995;65(11):793-5. 3355961
148. Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, et al. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. American Journal of Kidney Diseases 2009;53(6):1034-41. 3355963
149. Quenot JP. Citrate versus heparin for the lock of non-tunneled hemodialysis catheters in patients hospitalised in ICU. Multicentre, controlled, randomised superiority trial. clinicaltrials.gov/ct2/show/NCT01962116 (first received 27 August 2013). 3355971
150. Rajani K, Goetzman BW, Wennberg RP, Turner E, Abildgaard C. Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications. Pediatrics 1979;63(4):552-6. 3355975
151. Randon C. Prospective study which compares the use of a closing system without a needle and with positive pressure to a heparin lock with positive pressure for patients with a catheter for chemotherapy. clinicaltrials.gov/ct2/show/NCT00386451 (first received 10 October 2006). 3355977
152. Ray CE Jr, Shenoy SS, McCarthy PL, Broderick KA, Kaufman JA. Weekly prophylactic urokinase instillation in tunneled central venous access devices. Journal of Vascular and Interventional Radiology 1999;10(10):1330-4. 3355981
153. Reichardt P, Kretzschmar A, Biakhov M, Irwin D, Slabber C, Miller L, et al. A phase III double-blind, placebo-controlled study evaluating the efficacy and safety of daily low-molecular-weight heparin (dalteparin sodium, Fragmin) in preventing catheter-related complications in cancer patients with central venous catheters [abstract]. Journal of Clinical Oncology 2002; Vol. 21(Suppl):703a, Abstract 1474. 3355985
154. Rijnders BJ, Van WE, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. Journal of Antimicrobial Chemotherapy 2005;55(1):90-4. 3355989
155. Roberts GW, Holmes MD, Staugas RE, Day RA, Finlay CF, Pitcher A. Peripheral intravenous line survival and phlebitis prevention in patients receiving intravenous antibiotics: heparin/hydrocortisone versus in-line filters. Annals of Pharmacotherapy 1994;28(1):11-6. 3355991
156. Ruggiero RP, Aisenstein TJ. Central catheter fibrin sleeve - heparin effect. Journal of Parenteral and Enteral Nutrition 1983;7(3):270-3. 3355997
157. Sanders J, Pithie A, Ganly P, Surgenor L, Wilson R, Merriman E, et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. Journal of Antimicrobial Chemotherapy 2008;62(4):809-15. 3356001
158. Sang Sook H, Jee Eun P, Nam Eun K, Hwa Ja K. Effects of normal saline for maintenance of arterial lines of surgical patients. Journal of Korean Academy of Nursing 2012;42(6):791-8. 3356003
159. Saxena AK, Panhotra BR, Sundaram DS, Al-Hafiz A, Naguib M, Venkateshappa CK, et al. Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney International 2006;70(9):1629-35. 3356007
160. Saxena AK, Panhotra BR, Sundaram DS, Morsy MN, Al-Ghamdi AM. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial. Nephrology 2006;11(4):299-305. 3356009
161. Scherr K, Guenther C, Koshal A, Finegan B. Effects of heparinized vs non-heparinized flush solutions on patency of arterial and central pressure monitoring lines in the postoperative cardiac surgical patient. American Journal of Critical Care 2002;11(3):277. 3356011
162. Schouten H. Concentrated citrate locking to reduce the incidence of central venous catheter-related infections and thrombosis: a randomized phase III study in a hematological patient population. clinicaltrials.gov/ct2/show/NCT01820962 (first received 12 March 2013). 3356015
163. Schroder H. A randomised study of taurolock for the locking of tunneled central venous catheters in children with malignant diseases. clinicaltrials.gov/ct2/show/NCT00735813 (first received 14 August 2008). 3356017
164. Shirzad M, Espahbodi F, Baboli MT, Samakoosh MA, Khalilian A. Effects of heparin lock - antibiotics to prevent infections in patients undergoing hemodialysis: a clinical trial. Journal of Mazandaran University of Medical Sciences 2013;22(96):99-104. 3356035
165. Silva J, Teixeirae Costa, Baptista A, Ramos A, Ponce P. Catheter-related bacteremia in hemodialysis: which preventive measures to take?. Nephron 2008;110(4):251-7. 3356043
166. Silva TNV, Mendes ML, Abrao JMG, Caramori JT, Ponce D. Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin. International Urology and Nephrology 2013;45(5):1405-13. 3356045
167. Smith I, Hathaway M, Goldman C, Ng J, Brunton J, Simor AE, et al. A randomized study to determine complications associated with duration of insertion of heparin locks. Research in Nursing and Health 1990;13(6):367-73. 3356049
168. Sofroniadou S, Revela I, Smirloglou D, Makriniotou I, Zerbala S, Kouloubinis A, et al. Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study. Seminars in Dialysis 2012;25(3):344-50. 3356053
169. Solomon B, Moore J, Arthur C, Prince HM. Lack of efficacy of twice-weekly urokinase in the prevention of complications associated with Hickman catheters: a multicentre randomised comparison of urokinase versus heparin. European Journal of Cancer 2001;37(18):2379-84. 3356055
170. Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, et al. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. American Journal of Kidney Diseases 2010;55(6):1060-8. 3356057
171. Stas KJF, Vanwalleghem J, De Moor B, Keuleers H. Trisodium citrate 30% vs heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent haemodialysis. Nephrology Dialysis Transplantation 2001;16(7):1521-2. 3356063
172. Thomson PC, Morris ST, Mactier RA. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients. Clinical Nephrology 2011;75(3):212-7. 3356071
173. Thurlimann B, Bachmann I. Effective prevention of chemotherapy-induced phlebitis by low-dose heparin: a prospective randomised trial. Annals of Oncology 1992;3(4):311-3. 3356073
174. Tolar B, Gould JR. The timing and sequence of multiple device-related complications in patients with long-term indwelling Groshong catheters. Cancer 1996;78(6):1308-13. 3356075
175. Trottier SJ, Veremakis C, O'Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Critical Care Medicine 1995;23(1):52-9. 3356081
176. Tuncali BE, Kuvaki B, Tuncali B, Capar E. A comparison of the efficacy of heparinized and nonheparinized solutions for maintenance of perioperative radial arterial catheter patency and subsequent occlusion. Anesthesia and Analgesia 2005;100(4):1117-21. 3356083
177. Tuten SH, Gueldner SH. Efficacy of sodium chloride versus dilute heparin for maintenance of peripheral intermittent intravenous devices. Applied Nursing Research 1991;4(2):63-71. 3356085
178. Venditto M, du Montcel ST, Robert J, Trystam D, Dighiero J, Hue D, et al. Effect of catheter-lock solutions on catheter-related infection and inflammatory syndrome in hemodialysis patients: heparin versus citrate 46% versus heparin/gentamicin. Blood Purification 2010;29(3):268-73. 3356095
179. Vercaigne L. Efficacy and safety of an ethanol/sodium citrate locking solution to prevent hemodialysis catheter-related infections: a pilot study. clinicaltrials.gov/ct2/show/NCT01394458 (first received 4 July 2011). 8944611
180. Vercaigne LM. Efficacy and safety of an ethanol/sodium citrate locking solution: a pilot study. Vascular Access 2014; Vol. 8, issue 1:25. 8944613
181. Vercaigne LM, Allan DR, Armstrong SW, Zacharias JM, Miller LM. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study. Journal of Vascular Access 2016;17(1):55-62. 8944612
182. Verso M, Agnelli G, Bertoglio S, Di Somma FC, Paoletti F, Ageno W, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. Journal of Clinical Oncology 2005;23(18):4057-62. 3356099
183. Wang R, Luo O, He L, Li JX, Zhang MG. Preservative-free 0.9% sodium chloride for flushing and locking peripheral intravenous access device: a prospective controlled trial. Journal of Evidence-Based Medicine 2012;5(4):205-8. 3356107
184. Warkentin TE, Ling E, Ho A, Sheppard JI. 'Incidental' unfractionated heparin (UFH) vs normal saline (NS) flushes for intraoperative invasive catheters and the frequency of formation of heparin induced thrombocytopenia IgG antibodies (HIT-IgG): a randomized controlled trial. Blood 1998;92(10 Suppl 1):91. 3356109
185. Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. Journal of the American Society of Nephrology 2005;16(9):2769-77. 3356113
186. Whitta RK, Hall KF, Bennetts TM, Welman L, Rawlins P. Comparison of normal or heparinised saline flushing on function of arterial lines. Critical Care and Resuscitation 2006;8(3):205-8. 3356117
187. Witkovski MC. Continuous or intermittent for keeping arterial catheter in children: a randomized clinical trial. clinicaltrials.gov/show/NCT01097031 (first received 30 March 2010). 3356123
188. Wolf J. A double-blind, randomized, placebo-controlled trial of ethanol lock therapy for treatment and secondary prophylaxis of central line associated bloodstream infection (CLABSI) in children and adolescents. clinicaltrials.gov/show/NCT01472965 (first received 14 November 2011). 3356125
189. Wong FSY, Cheng YL, Chow NY, Cheung ALC, Chau SK, Ngai MS, et al. Effect of 3 different solutions used for locking hemodialysis catheter on systemic coagulation: a randomized study. Hemodialysis International 2009;13(3):403. 3356129
190. Xu L, Hu Y, Huang X, Fu J, Zhang J. Heparinized saline versus normal saline for maintaining peripheral venous catheter patency in China: an open-label, randomized controlled study. Journal of International Medical Research 2017;45(2):471-80. 8944615
191. Young AM, Billingham LJ, Begum G, Kerr DJ, Hughes AI, Rea DW, et al. WARP Collaborative Group, UK. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 2009;373(9663):567-74. 3356143
192. Zacharski LR, Prandoni P, Monreal M. Warfarin versus low-molecular-weight heparin therapy in cancer patients. Oncologist 2005;10(1):72-9. 3356145
193. Zhang P, Yuan J, Tan HZ, Lv R, Chen JH. Successful prevention of cuffed hemodialysis catheter-related infection using an antibiotic lock technique by strictly catheter-restricted antibiotic lock solution method. Blood Purification 2009;27(2):206-11. 3356147
194. Ziyaeifard M, Alizadehasl A, Aghdaii N, Sadeghi A, Azarfarin R, Masoumi G, Golbargian G. Heparinized and saline solutions in the maintenance of arterial and central venous catheters after cardiac surgery. Anesthesiology and Pain Medicine 2015;5(5):e28056. 8944617
195. Klein J, Patterson A, Jepsen A, Badgero K, Moore M, Warrell WA, et al. Effectiveness of heparin versus saline flushing for managing central venous catheters (CVCs) in the blood and marrow transplant (BMT) patients: a pilot study. Biology of Blood and Marrow Transplantation 2017;23(3 Suppl 1):S386. 8944619
196. Klein J, Jepsen A, Patterson A, Reich RR, Mason TM. Heparin versus normal saline: flushing effectiveness in managing central venous catheters in patients undergoing blood and marrow transplantation. Clinical Journal of Oncology Nursing 2018;22(2):1-5. 8944621
197. NCT02354118. Maintaining patency in implanted port catheters. clinicaltrials.gov/ct2/show/NCT02354118 (first received 29 January 2015). 8944623
198. NCT02923830. Maintaining patency in BioFlo implanted port catheters with saline only flushes. clinicaltrials.gov/ct2/show/NCT02923830 (first received 30 September 2016). 8944625
199. RBR-3ht499. Effectiveness of heparin solution in preventing Hickman® catheter occlusion: clinical trial. RBR-3ht499 [Efetividade da solução de heparina na prevenção de oclusão do cateter de Hickman®: ensaio clínico]. ensaiosclinicos.gov.br/rg/RBR-3ht499/ (first received 16 March 2017):(UTN Number: U1111-1194-3653). 8944627
200. Battistelli S, Genovese A, Gori T. Heparin-induced thrombocytopenia in surgical patients. American Journal of Surgery 2010;199(1):43-51.
201. Bern MM, Lokich JJ, Wallach SR, Bothe A, Benotti PN, Arkin CF, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Annals of Internal Medicine 1990;112(6):423-8.
202. Bishop L. Aftercare and management of central venous access devices. In: Hamilton H, Bodenham A editor(s). Central Venous Catheters. 1st Edition. Chichester: Wiley & Blackwell, 2009:221-37.
203. Bradford NK, Edwards RM, Chan RJ. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children. Cochrane Database of Systematic Reviews 2015, Issue 11. [DOI: 10.1002/14651858.CD010996.pub2]
204. Bradford NK, Edwards RM, Chan RJ. Heparin versus 0.9% sodium chloride intermittent flushing for the prevention of occlusion in long term central venous catheters in infants and children: a systematic review. International Journal of Nursing Studies 2016;59:51-9.
205. Burns KE, McLaren A. A critical review of thromboembolic complications associated with central venous catheters. Canadian Journal of Anaesthesia 2008;55(8):532-41.
206. Dal Molin A, Allara E, Montani D, Milani S, Frassati C, Cossu S, et al. Flushing the central venous catheter: is heparin necessary?. Journal of Vascular Access 2014;15(4):241-8.
207. Eisen LA, Narasimhan M, Berger JS, Mayo PH, Rosen MJ, Schneider RF. Mechanical complications of central venous catheters. Journal of Intensive Care Medicine 2006;21(1):40-6.
208. Goode CJ, Titler M, Rakel B, Ones DS, Kleiber C, Small S, et al. A meta-analysis of effects of heparin flush and saline flush: quality and cost implications. Nursing Research 1991;40(6):324-30.
209. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed August 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015.
210. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. British Medical Journal 2008;336(7650):924-6.
211. Higgins JPT, Thompson SG, Deeks JJ, Altmann DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327(7414):557-60.
212. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
213. Gorski LA. INS Learning Center: Infusion Therapy Standards of Practice 2016. learningcenter.ins1.org/products/infusion-therapy-standards-of-practice-2016 (accessed 9 May 2017).
214. Jacobs BR. Central venous catheter occlusion and thrombosis. Critical Care Clinics 2003;19(3):489-514.
215. Jonker MA, Osterby KR, Vermeulen LC, Kleppin SM, Kudsk KA. Does low-dose heparin maintain central venous access device patency? A comparison of heparin versus saline during a period of heparin shortage. Journal of Parenteral and Enteral Nutrition 2010;34(4):444-9. [PUBMED: 20631392]
216. Klerk CPW, Smorenburg SM, Büller HR. Thrombosis prophylaxis in patient populations with a central venous catheter. Archives of Internal Medicine 2003;163(16):1913-21.
217. Lee DH, Warkentin TE. Frequency of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A editor(s). Heparin-Induced Thrombocytopenia. 4th Edition. New York: Informa Healthcare, 2007:67-116.
218. López-Briz E, Ruiz-Garcia V. Effectiveness of heparin versus NaCl 0.9% in central venous catheter flushing. A systematic review [Heparina frente a cloruro sódico 0, 9% para mantener permeables los catéteres venosos centrales. Una revisión sistemática]. Farmacia Hospitalaria 2005;29(4):258-64.
219. Martel N, Lee J, Wells PS. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis. Blood 2005;106(8):2710-5.
220. McGee DC, Gould MK. Preventing complications of central venous catheterization. New England Journal of Medicine 2003;348(12):1123-33.
221. McNulty I, Katz E, Kim KY. Thrombocytopenia following heparin flush. Progress in Cardiovascular Nursing 2005;20(4):143-7.
222. McQuay HJ, Moore RA. Using numerical results from systematic reviews in clinical practice. Annals of Internal Medicine 1997;126(9):712-20.
223. Mermel LA. Prevention of intravascular catheter-related infections. Annals of Internal Medicine 2000;132(5):391-402.
224. Merrer J, De Jonghe B, Golliot F, Lefrant JY, Raffy E, Barre E, et al. French Catheter Study Group in Intensive Care. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. Journal of the American Medical Association 2001;286(6):700-7.
225. Mitchell MD, Anderson BJ, Williams K, Umscheid CA. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review. Journal of Advanced Nursing 2009;65(10):2007-21.
226. Raad I, Darouiche R, Dupuis J, Abi-Said D, Gabrielli A, Hachem R, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Annals of Internal Medicine 1997;127(4):267-74.
227. Randolph AG. An evidence-based approach to central venous catheter management to prevent catheter-related infection in critically ill patients. Critical Care Clinics 1998;14(3):411-21.
228. Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials. Chest 1998;113(1):165-71.
229. Shah PS, Shah VS. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters. Cochrane Database of Systematic Reviews 2008, Issue 2. [DOI: 10.1002/14651858.CD002772.pub3]
230. Smith RN. Central venous catheters. British Medical Journal 2013;347:f6570. [DOI: 10.1136/bmj.f6570]
231. Sona C, Prentice D, Schallom L. National survey of central venous catheter flushing in the intensive care unit. Critical Care Nurse 2012;32(1):e12-9.
232. Sousa B, Furlanetto J, Hutka M, Gouveia P, Wuerstlein R, Mariz JM, et al. Central venous access in oncology: ESMO Clinical Practice Guidelines. Annals of Oncology 2015; Vol. 26, issue Suppl 5:v152-68.
233. Valerio D, Hussey JK, Smith FW. Central vein thrombosis associated with intravenous feeding - a prospective study. Journal of Parenteral and Enteral Nutrition 1981;5(3):240-2.
234. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. Journal of the American Medical Association 1999;281(3):261-7.
235. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. Journal of Clinical Oncology 2003;21(19):3665-75.
236. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A editor(s). Heparin-Induced Thrombocytopenia. 4th Edition. New York: Informa Healthcare, 2007:21-66.
237. Zhong L, Wang HL, Xu B, Yuan Y, Wang X, Zhang YY, et al. Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis. Critical Care 2017;21(1):5. [PUBMED: 28063456]
238. López-Briz E, Ruiz Garcia V, Cabello JB, Bort-Marti S, Carbonell Sanchis R, Burls A. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews 2010, Issue 4. [DOI: 10.1002/14651858.CD008462]
239. López-Briz E, Ruiz Garcia V, Cabello JB, Bort-Marti S, Carbonell Sanchis R, Burls A. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults. Cochrane Database of Systematic Reviews 2014, Issue 10. [DOI: 10.1002/14651858.CD008462.pub2]